![logo](/logos/002030.SZ.webp)
Daan Gene Co., Ltd.
SZSE:002030.SZ
9.48 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 1,171.115 | 12,046.135 | 7,664.262 | 5,341.21 | 1,098.217 | 1,478.663 | 1,542.429 | 1,612.56 | 1,474.339 | 1,086.153 | 854.372 | 582.692 | 457.56 | 369.968 | 319.601 | 239.204 | 207.276 | 172.539 | 162.472 | 155.862 | 132.49 | 102.155 | 72.083 |
Cost of Revenue
| 737.689 | 3,271.535 | 1,934.079 | 1,561.728 | 551.074 | 863.367 | 877.02 | 912.261 | 919.512 | 631.274 | 436.395 | 259.832 | 204.336 | 152.877 | 133.292 | 86.949 | 83.126 | 73.699 | 71.523 | 71.985 | 73.626 | 61.722 | 44.09 |
Gross Profit
| 433.426 | 8,774.6 | 5,730.183 | 3,779.482 | 547.143 | 615.296 | 665.409 | 700.299 | 554.827 | 454.88 | 417.977 | 322.861 | 253.224 | 217.091 | 186.309 | 152.255 | 124.15 | 98.84 | 90.949 | 83.877 | 58.864 | 40.433 | 27.993 |
Gross Profit Ratio
| 0.37 | 0.728 | 0.748 | 0.708 | 0.498 | 0.416 | 0.431 | 0.434 | 0.376 | 0.419 | 0.489 | 0.554 | 0.553 | 0.587 | 0.583 | 0.637 | 0.599 | 0.573 | 0.56 | 0.538 | 0.444 | 0.396 | 0.388 |
Reseach & Development Expenses
| 189.061 | 702.404 | 508.802 | 166.947 | 94.914 | 86.128 | 94.259 | 16.077 | 21.3 | 70.333 | 53.513 | 58.03 | 0 | 0 | 0 | 12.696 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 38.29 | 26.758 | 113.655 | 46.191 | 23.442 | 71.139 | 117.908 | 96.125 | 68.316 | 63.584 | 62.804 | 69.284 | 37.168 | 30.435 | 81.682 | 18.355 | 40.397 | 32.033 | 29.399 | 21.508 | 18.463 | 11.252 | 8.185 |
Selling & Marketing Expenses
| 172.833 | 939.512 | 790.207 | 666.96 | 194.007 | 208.166 | 274.591 | 289.092 | 230.631 | 169.265 | 162.556 | 132.835 | 90.967 | 68.479 | 52.963 | 52.739 | 37.198 | 32.024 | 27.368 | 29.722 | 7.63 | 2.206 | 1.031 |
SG&A
| 414.686 | 966.27 | 903.862 | 713.151 | 217.448 | 279.304 | 392.498 | 385.218 | 298.947 | 232.849 | 225.361 | 202.119 | 128.134 | 98.915 | 134.645 | 71.094 | 77.594 | 64.057 | 56.767 | 51.23 | 26.093 | 13.457 | 9.216 |
Other Expenses
| -191.36 | 266.258 | 180.907 | 173.602 | 34.064 | 89.235 | 1.067 | 51.807 | 50.714 | 23.131 | 19.231 | 12.907 | 28.039 | 27.46 | 15.724 | 13.505 | 3.382 | 1.473 | 0.016 | -0.014 | 0.161 | 1.554 | -0.318 |
Operating Expenses
| 795.108 | 1,934.932 | 1,593.572 | 1,053.7 | 346.426 | 454.667 | 518.577 | 554.294 | 437.546 | 339.325 | 319.942 | 285.7 | 198.987 | 168.52 | 139.16 | 117.402 | 81.349 | 64.317 | 60.103 | 51.6 | 29.303 | 16.856 | 9.792 |
Operating Income
| -361.681 | 6,329.254 | 4,125.397 | 2,940.089 | 295.305 | 212.992 | 110.878 | 101.005 | 87.035 | 172.91 | 152.456 | 80.752 | 50.851 | 42.505 | 41.668 | 34.477 | 39.678 | 34.948 | 32.224 | 30.062 | 27.474 | 21.999 | 17.262 |
Operating Income Ratio
| -0.309 | 0.525 | 0.538 | 0.55 | 0.269 | 0.144 | 0.072 | 0.063 | 0.059 | 0.159 | 0.178 | 0.139 | 0.111 | 0.115 | 0.13 | 0.144 | 0.191 | 0.203 | 0.198 | 0.193 | 0.207 | 0.215 | 0.239 |
Total Other Income Expenses Net
| 521.318 | -10.318 | -5.316 | -37.223 | -289.255 | -111.166 | -34.887 | 6.003 | 19.343 | 80.36 | 73.301 | 56.412 | 24.618 | 21.304 | 10.184 | 13.048 | 0.157 | 1.845 | 1.256 | -2.229 | -1.925 | -1.604 | -1.256 |
Income Before Tax
| 159.637 | 6,318.937 | 4,120.081 | 2,902.866 | 6.05 | 101.825 | 111.945 | 152.009 | 136.624 | 195.915 | 171.337 | 93.573 | 78.855 | 69.875 | 57.333 | 47.901 | 42.958 | 36.394 | 32.171 | 30.048 | 27.635 | 21.974 | 16.944 |
Income Before Tax Ratio
| 0.136 | 0.525 | 0.538 | 0.543 | 0.006 | 0.069 | 0.073 | 0.094 | 0.093 | 0.18 | 0.201 | 0.161 | 0.172 | 0.189 | 0.179 | 0.2 | 0.207 | 0.211 | 0.198 | 0.193 | 0.209 | 0.215 | 0.235 |
Income Tax Expense
| 41.804 | 891.378 | 501.595 | 452.821 | 53.21 | 15.314 | 15.825 | 16.096 | 18.872 | 37.294 | 34.356 | 7.598 | 11.603 | 11.567 | 9.537 | 8.275 | 8.754 | 8.208 | 5.84 | 4.915 | 4.593 | 3.451 | 2.845 |
Net Income
| 104.66 | 5,412.341 | 3,618.187 | 2,449.09 | -47.159 | 101.583 | 86.448 | 106.686 | 101.237 | 153.056 | 133.275 | 90.165 | 68.011 | 56.453 | 47.356 | 39.108 | 35.036 | 28.077 | 26.297 | 25.2 | 23.093 | 18.565 | 14.088 |
Net Income Ratio
| 0.089 | 0.449 | 0.472 | 0.459 | -0.043 | 0.069 | 0.056 | 0.066 | 0.069 | 0.141 | 0.156 | 0.155 | 0.149 | 0.153 | 0.148 | 0.163 | 0.169 | 0.163 | 0.162 | 0.162 | 0.174 | 0.182 | 0.195 |
EPS
| 0.075 | 3.86 | 2.58 | 1.75 | -0.034 | 0.072 | 0.063 | 0.078 | 0.072 | 0.11 | 0.1 | 0.065 | 0.047 | 0.04 | 0.033 | 0.031 | 0.029 | 0.025 | 0.023 | 0.022 | 0.027 | 0.029 | 0.029 |
EPS Diluted
| 0.075 | 3.86 | 2.58 | 1.75 | -0.034 | 0.072 | 0.063 | 0.078 | 0.072 | 0.11 | 0.1 | 0.065 | 0.047 | 0.04 | 0.033 | 0.031 | 0.029 | 0.025 | 0.023 | 0.022 | 0.027 | 0.029 | 0.029 |
EBITDA
| 3.596 | 7,605.373 | 4,498.821 | 3,190.978 | 371.027 | 300.564 | 264.288 | 288.676 | 232.77 | 268.135 | 224.243 | 141.699 | 124.645 | 108.517 | 94.288 | 86.315 | 74.094 | 60.493 | 63.258 | 61.538 | 54.756 | 42.544 | 18.333 |
EBITDA Ratio
| 0.003 | 0.631 | 0.587 | 0.597 | 0.338 | 0.203 | 0.171 | 0.179 | 0.158 | 0.247 | 0.262 | 0.243 | 0.272 | 0.293 | 0.295 | 0.361 | 0.357 | 0.351 | 0.389 | 0.395 | 0.413 | 0.416 | 0.254 |